Lumenis Be Ltd.
The study incudes 18 to 55 y/o healthy subjects with moderate hair loss stage and Fitzpatrick skin type 5 or 6
The FoLix laser system contains Erbium:Glass Fiber Laser Technology with a wavelength of 1565 nm. It is the first FDA cleared fractional laser device for treatment of hair loss that has demonstrated safety and efficacy.
Inclusion Criteria: * Male and females between 21 - 55 years of age, inclusive. * Have Fitzpatrick Skin Type V to VI. * Have mild to moderate hair loss (Ludwig scale I-II for women, Norwood-Hamilton scale I-III for males) * Have self-reported thinning or hair loss for more than 6 months prior to screening but less than 5 years. * Clinically confirmed to have hair loss or thinning by the investigator via physical exam * Didn't receive hair-loss treatments or participated in a clinical study using 1565 NAFL device * In good general health, as determined by the Investigator * Willing and able to…
The study patients will receive 4 FoLix treatment in 4 weeks intervals. the scalp hair improvement will be evaluated by 3 blinded assessors who shall review before and after images, as well as hair count data
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.